Search Results

Faster clearance of mirodenafil in rats with acute renal failure induced by uranyl nitrate: contribution of increased protein expression of hepatic CYP3A1 and intestinal CYP1A1 and 3A1/2

Authors: Choi, Young H.; Lee, Young S.; Kim, Tae K.; Lee, Bong-Y.; Lee, Myung G.

Source: Journal of Pharmacy and Pharmacology, Volume 61, Number 10, October 2009 , pp. 1325-1332(8)

Publisher: Pharmaceutical Press

Efficacy and Safety of Mirodenafil, A New Oral Phosphodiesterase Type 5 Inhibitor, for Treatment of Erectile Dysfunction

Authors: Paick, Jae-Seung; Ahn, Tai Y.; Choi, Hyung K.; Chung, Woo-Sik; Kim, Je J.; Kim, Sae C.; Kim, Sae W.; Lee, Sung W.; Min, Kweon S.; Moon, Ki H.; Park, Jong K.; Park, Kwangsung; Park, Nam C.; Suh, Jun-Kyu; Yang, Dae Y.; Jung, Hyung-Gi

Source: The Journal of Sexual Medicine, Volume 5, Number 11, November 2008 , pp. 2672-2680(9)

Publisher: Blackwell Publishing

Novel phosphodiesterase-5 (PDE5) inhibitors in the alleviation of erectile dysfunction due to diabetes and ageing-induced oxidative stress

Authors: Gur, Serap; Sikka, Suresh C; Hellstrom, Wayne JG

Source: Expert Opinion on Investigational Drugs, Volume 17, Number 6, June 2008 , pp. 855-864(10)

Publisher: Informa Healthcare

Looking to the Future for Erectile Dysfunction Therapies

Authors: Hatzimouratidis, Konstantinos; Hatzichristou, Dimitrios G.

Source: Drugs, Volume 68, Number 2, 2008 , pp. 231-250(20)

Publisher: Adis International